Top Markets
Coin of the day
Voronoi, Inc. Voronoi, Inc.

Voronoi, Inc.

310210
Clasificación en acciones #6296
Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a... Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a biotechnology company dedicated to the research, development, and identification of small molecule kinase inhibitors. Its extensive product pipeline addresses various medical needs. Key candidates include VRN01, an oral leucine-rich repeat kinase 2 (LRRK2) inhibitor, being developed for glioblastoma multiforme, brain cancer, and pancreatic cancer. Treatments for lung cancer are represented by VRN07, VRN06, and VRN11, while VRN08 and VRN10 are in development for breast cancer. Additionally, VRN02 targets rheumatoid arthritis and atopic dermatitis. The company's pipeline further encompasses VRN04-1 for autoimmune conditions, VRN04-2 for multiple sclerosis and amyotrophic lateral sclerosis (ALS), VRN13 for pulmonary arterial hypertension, and VRN14 for challenging solid tumors.
Precio por acción
$115.48
Capitalización bursátil
$2.12B
Cambio (1 día)
0.72%
Cambio (1 año)
29.38%
País
KR
Comercio Voronoi, Inc. (310210)

Categoría

Historial del precio de la acción de Voronoi, Inc. (310210)
Precio más alto de cierre: $117.55 el 2026-08-01

Precio más bajo de cierre: $21.91 el 2022-06-01
Historial del precio de la acción de Voronoi, Inc. desde 2022 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.57%
2025 181.09%
2024 62.84%
2023 71.45%
2022 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$548.25 40.91%
US
$1.05K 48.60%
NL
$122.63 -12.65%
AU
$142.40 467.33%
US
$765.25 7.19%
CH